Business Context and Reporting Period
This Form 8-K Current Report was filed by Accuray Incorporated on April 26, 2011. The filing addresses the status of the previously announced Agreement and Plan of Merger with TomoTherapy Incorporated, dated March 6, 2011.
Key Financial Metrics
This filing is a current report regarding a corporate event and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes
The primary material event reported is the expiration of the mandatory pre-merger waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) on April 26, 2011. This regulatory clearance is a necessary condition for the proposed merger between Accuray and TomoTherapy to proceed.
Guidance, Outlook, and Risks
The filing includes standard forward-looking statements regarding the transaction. Management notes that the merger is subject to the satisfaction or waiver of certain closing conditions. Key risks and uncertainties identified include:
- The satisfaction of closing conditions for the transaction.
- Market conditions and general industry/economic factors.
- The effect of the announcement on both companies' businesses.
- The risk of failure to complete the transaction.
- The potential inability to successfully integrate TomoTherapy's business.
- Failure to realize anticipated benefits of the transaction.
The filing explicitly states it is not a substitute for the proxy statement or registration statement and does not constitute an offer to sell or purchase securities.
Investor Verification Checklist
- Verify the final terms of the Merger Agreement in the Preliminary Registration Statement on Form S-4 filed April 7, 2011.
- Monitor the filing of the proxy statement by TomoTherapy for shareholder voting details.
- Review the Risk Factors sections in Accuray's Form 10-Q (ended Dec 31, 2010) and TomoTherapy's Form 10-K (ended Dec 31, 2010).
- Confirm the satisfaction of all remaining closing conditions beyond HSR clearance.